308 related articles for article (PubMed ID: 19173987)
1. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
[TBL] [Abstract][Full Text] [Related]
2. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin.
Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD
Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188
[TBL] [Abstract][Full Text] [Related]
3. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
Lee HS; Kim BH; Cho NY; Yoo EJ; Choi M; Shin SH; Jang JJ; Suh KS; Kim YS; Kang GH
Clin Cancer Res; 2009 Feb; 15(3):812-20. PubMed ID: 19188151
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
6. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
7. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
[TBL] [Abstract][Full Text] [Related]
8. [Gene expression profile of human hepatocellular carcinoma cell lines with different metastatic potentials].
Li Y; Tang Z; Ye S; Liu B; Liu Y; Chen J; Xue Q
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):533-6. PubMed ID: 12667318
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
10. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
12. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
Qiu G; Fang J; He Y
Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.
Schagdarsurengin U; Wilkens L; Steinemann D; Flemming P; Kreipe HH; Pfeifer GP; Schlegelberger B; Dammann R
Oncogene; 2003 Mar; 22(12):1866-71. PubMed ID: 12660822
[TBL] [Abstract][Full Text] [Related]
14. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
[TBL] [Abstract][Full Text] [Related]
15. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
Kiran M; Chawla YK; Kaur J
Cancer Genet Cytogenet; 2009 Dec; 195(2):112-9. PubMed ID: 19963110
[TBL] [Abstract][Full Text] [Related]
16. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
[TBL] [Abstract][Full Text] [Related]
18. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
[TBL] [Abstract][Full Text] [Related]
20. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]